Drug class
Parathyroid Hormone
The parathyroid hormone class encompasses full-length recombinant human parathyroid hormone as well as synthetic or prodrug analogs that act as agonists at the parathyroid hormone type 1 receptor (PTH1R). Read more about Parathyroid Hormone
9 drugs in this class 8 manufacturers
Drugs in Parathyroid Hormone
TERIPARATIDE
TERIPARATIDE
TERIPARATIDE
YORVIPATH (palopegteriparatide)
TERIPARATIDE
BONSITY (teriparatide)
TERIPARATIDE
TERIPARATIDE
The parathyroid hormone class encompasses full-length recombinant human parathyroid hormone as well as synthetic or prodrug analogs that act as agonists at the parathyroid hormone type 1 receptor (PTH1R).
Depending on the specific agent and dosing kinetics, these therapeutics either serve as hormone replacement to restore calcium and phosphate homeostasis or stimulate osteoblast activity to induce bone formation.
Clinically, medications in this class are primarily indicated for managing hypocalcemia in chronic hypoparathyroidism and treating severe osteoporosis in individuals at high risk for fracture.
-
fda.gov
The parathyroid hormone class encompasses full-length recombinant human parathyroid hormone as well as synthetic or prodrug analogs that act as agonists at the parathyroid hormone type 1 receptor (PTH1R) Clinically, medications in this class are primarily indicated for managing hypocalcemia in chronic hypoparathyroidism and treating severe osteoporosis in individuals at high risk for fracture
-
fda.gov
The parathyroid hormone class encompasses full-length recombinant human parathyroid hormone as well as synthetic or prodrug analogs that act as agonists at the parathyroid hormone type 1 receptor (PTH1R)
-
fda.gov
Depending on the specific agent and dosing kinetics, these therapeutics either serve as hormone replacement to restore calcium and phosphate homeostasis or stimulate osteoblast activity to induce bone formation
-
nih.gov
Depending on the specific agent and dosing kinetics, these therapeutics either serve as hormone replacement to restore calcium and phosphate homeostasis or stimulate osteoblast activity to induce bone formation
-
nih.gov
Depending on the specific agent and dosing kinetics, these therapeutics either serve as hormone replacement to restore calcium and phosphate homeostasis or stimulate osteoblast activity to induce bone formation
-
fda.gov
Clinically, medications in this class are primarily indicated for managing hypocalcemia in chronic hypoparathyroidism and treating severe osteoporosis in individuals at high risk for fracture
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.